Mopiko
Mopiko, licence 80007867: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Topwin Trading Co., Ltd.
- NPN or DIN-HM
- 80007867
- Status
- Active licence
- Licence date
- 30 September 2008
- Revision date
- Not provided
- Form
- Onguent
- Route of administration
- Topique
- Application type
- TPD Cat IV/LS
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,7,7-Triméthylbicyclo[2.2.1]heptan-2-one | 5.83 % | Not calculated |
Non-medicinal ingredients
Ointment, White USP, Salicylate de méthyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | minimum: 3.0 Tous les jours ; maximum: 4.0 Tous les jours |
| Enfants | minimum: 2.0 Année(s) | Not specified | minimum: 3.0 Tous les jours ; maximum: 4.0 Tous les jours |
Uses authorised in Canada
For the temporary relief of aches and pains of muscles and joints associated with backache, lumbago, strains, bruises, sprains and arthritic or rheumatic pain, pain of tendons and ligaments. For tired and aching muscles.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If conditions worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use and consult a health care practitioner. For external use only. If rash or irritation occurs, discontinue use. The application of external heat, such as an electric heating pad, may result in excessive skin irritation or skin burn.
Source
Official Health Canada record, licence 80007867
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.